Latest news and articles about biotechnology from NEX English
The National Medical Products Administration in China has approved 19 innovative drugs, with 15 being locally developed. This marks a significant surge in the country's biotechnology sector.
Demis Hassabis, co-founder and CEO of Google's DeepMind, announced the launch of Isomorphic Labs. The company aims to leverage artificial intelligence technologies to accelerate the development of new drugs, marking a significant step in the biotechnology field.
Odyssey Therapeutics, a biotech company focused on developing treatments for immune and inflammatory diseases, has announced plans to raise <strong>$238.3 million</strong> through an initial public offering (IPO) in the United States. This announcement comes at a time of increasing investor interest in the biotech industry.
Bion Company has announced its financial results for the third quarter of the year, showing a significant improvement in performance compared to previous periods. These results reflect the company's strategy for expansion and growth.
American companies like <strong>Preventive</strong> and <strong>Origin Genomics</strong> are advancing gene editing technologies in embryos, raising concerns about a return to eugenics. These controversial techniques could significantly alter the future of humanity.
China is making remarkable strides in the fields of pharmaceuticals and biotechnology, with a notable increase in research conducted by Chinese scientists. This rapid development indicates China's growing ability to compete with the United States in this vital sector.
Ras Al Khaimah is set to host the inaugural Biotechnology Conference in 2026, a significant event aimed at fostering collaboration between researchers and investors in the vital sector. This conference will serve as a platform for exchanging innovative ideas in the field of life sciences.
Eli Lilly and Company has announced its agreement to acquire Kilonia Therapeutics, a company specializing in gene delivery technologies, in a deal valued at $7 billion. This move aims to enhance Eli Lilly's capabilities in the field of genetic therapies.
Scientists from the National Research Center 'Kurchatov Institute' have developed a new biotechnological method for generating oxygen aboard the International Space Station, in collaboration with the Institute of Biomedical Problems. This technology represents a significant step towards enhancing sustainability in space.
China has announced stricter measures for companies seeking listings through offshore structures, increasing challenges for dollar-denominated investment funds. This move reflects Beijing's commitment to monitor sensitive industries and prevent asset sales that evade regulatory oversight.
MAK Capital, led by Michael Kaufman, urges Evotec SE to list its US unit on the stock market and accelerate its cost-cutting program after its shares plummeted by about 85% over the past five years.
Chinese biotech companies recorded a staggering $60 billion in cross-border licensing deals in the first quarter of 2026, reflecting a growing interest from multinational corporations in promising drug candidates from China. This marks a significant increase of 73% compared to the same period last year.
An Australian company has announced the development of a groundbreaking device that allows code execution on live human brain cells. This innovative system merges lab-grown neurons with silicon technology, opening new horizons in various fields.
Anthropic has announced its acquisition of the biotech startup Cohere Bio in a deal valued at <strong>$400 million</strong>. This acquisition aims to enhance Anthropic's capabilities in artificial intelligence and biotechnology.
Chinese scientists have unveiled genetically modified plants capable of glowing in the dark, potentially revolutionizing urban lighting, tourism, and sustainable design. These plants were developed using gene editing techniques to transfer luminous genes from fireflies and bioluminescent fungi into plant cells.
Russian biotechnology expert Alexey Sturgin has revealed the potential for human life expectancy to rise to 100 years in the near future, citing several key factors necessary to achieve this goal. Advances in medical science and public health are pivotal to this change.
Eli Lilly has announced a new partnership with Insilico Medicine aimed at developing drugs entirely designed by artificial intelligence. The deal, valued at approximately <strong>$2.75 billion</strong>, will enhance the company's efforts in discovering new treatments for various diseases.
Hua Medicine, a leading Chinese biotechnology firm, announced a remarkable revenue growth of <strong>93%</strong> for 2026. In an exclusive interview with Bloomberg's 'China' program, Strategic Director George Lin discussed the prospects of the company's main drug, Duzaglitin, and plans for expansion into new markets.
A team of scientists has achieved a groundbreaking scientific feat by transferring a complete genome from a living bacteria to a dead one, successfully bringing it back to life. This unprecedented achievement in synthetic biology opens new avenues for understanding biological processes and genetic engineering possibilities.
A group of billionaires worldwide is investing in a biotechnology company focused on producing genetically modified monkey organs, paving the way for the potential creation of human organs in laboratories. This initiative could revolutionize the future of organ transplantation.
The Catholic Church has issued new guidelines permitting the use of animal organs in human transplants, emphasizing the need for medical and ethical standards. This announcement comes amid a growing demand for organ transplants worldwide.